Works by Novotny W

Results: 20

Palpable Purpura.

Published in:

American Family Physician, 2024, v. 109, n. 3, p. 265

By:

Novotny, Richard W.;
Trinh, Lien N.;
Gowan, Amy J.;
Lomeli, Matthew C.

Publication type:

Article

ZANUBRUTINIB FOR PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA.

Published in:

Hematological Oncology, 2019, v. 37, p. 87, doi. 10.1002/hon.55_2629

By:

Xu, W.;
Yang, S.;
Zhou, K.;
Pan, L.;
Li, Z.;
Zhou, J.;
Gao, S.;
Zhou, D.;
Hu, J.;
Feng, R.;
Huang, H.;
Ji, M.;
Guo, H.;
Huang, J.;
Novotny, W.;
Feng, S.;
Li, J.

Publication type:

Article

ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 45, doi. 10.1002/hon.15_2629

By:

Song, Y.;
Zhou, K.;
Zou, D.;
Zhou, J.;
Hu, J.;
Yang, H.;
Zhang, H.;
Ji, J.;
Xu, W.;
Jin, J.;
Lv, F.;
Feng, R.;
Gao, S.;
Zhou, D.;
Guo, H.;
Wang, A.;
Elstrom, R.;
Huang, J.;
Novotny, W.;
Han, L.

Publication type:

Article

ZANUBRUTINIB FOR PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA.

Published in:

Hematological Oncology, 2019, v. 37, p. 87, doi. 10.1002/hon.55_2629

By:

Xu, W.;
Yang, S.;
Zhou, K.;
Pan, L.;
Li, Z.;
Zhou, J.;
Gao, S.;
Zhou, D.;
Hu, J.;
Feng, R.;
Huang, H.;
Ji, M.;
Guo, H.;
Huang, J.;
Novotny, W.;
Feng, S.;
Li, J.

Publication type:

Article

ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA.

Published in:

Hematological Oncology, 2019, v. 37, p. 45, doi. 10.1002/hon.15_2629

By:

Song, Y.;
Zhou, K.;
Zou, D.;
Zhou, J.;
Hu, J.;
Yang, H.;
Zhang, H.;
Ji, J.;
Xu, W.;
Jin, J.;
Lv, F.;
Feng, R.;
Gao, S.;
Zhou, D.;
Guo, H.;
Wang, A.;
Elstrom, R.;
Huang, J.;
Novotny, W.;
Han, L.

Publication type:

Article

SAFETY AND ACTIVITY OF THE HIGHLY SPECIFIC BTK INHIBITOR, BGB-3111 PLUS OBINUTUZUMAB IN PATIENTS (PTS) WITH FOLLICULAR LYMPHOMA (FL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).

Published in:

Hematological Oncology, 2017, v. 35, p. 113, doi. 10.1002/hon.2437_102

By:

Tam, C.S.;
Quach, H.;
Nicol, A.;
Badoux, X.;
Rose, H.;
Prince, H.;
Leahy, M.F.;
Eek, R.;
Wickham, N.;
Patil, S.;
Huang, J.;
Zhang, X.;
Wang, L.;
Hedrick, E.;
Novotny, W.;
Flinn, I.

Publication type:

Article

A HEAD-TO-HEAD PHASE 3 STUDY COMPARING BGB-3111 AND IBRUTINIB IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA.

Published in:

Hematological Oncology, 2017, v. 35, p. 422, doi. 10.1002/hon.2440_5

By:

Buske, C.;
LeBlond, V.;
Novotny, W.;
Owen, R.;
Tedeschi, A.;
Atwal, S.;
Cohen, A.;
Huang, J.;
Tam, C.S.

Publication type:

Article

The Aftermath of AT&T Mobility v. Concepcion: Are Class Actions Now Extinct?

Published in:

Dispute Resolution Journal, 2012, v. 67, n. 2, p. 5

By:

Novotny, Ronald W.

Publication type:

Article

A second case of Hb hanamaki [α<sub>2</sub>139 (HC1) LYS→GLU β<sub>2</sub>] in an american family with erythrocytosis.

Published in:

Hemoglobin, 1994, v. 18, n. 3, p. 221, doi. 10.3109/03630269409043622

By:

Rahbar, S.;
Lee, T. D.;
Davis, M.;
Novotny, W. F.;
Ranney, H. M.

Publication type:

Article

INNOVATION TESTING OF BENDING OF THE MACHINE-TOOL FRAMES.

Published in:

MM Science Journal, 2016, p. 1625, doi. 10.17973/MMSJ.2016_12_2016199

By:

UCEN, OLDRICH;
NOVOTNY, LUBOMIR W.

Publication type:

Article

Clinical pharmacokinetics of bevacizumab in patients with solid tumors.

Published in:

2008

By:

Lu JF;
Bruno R;
Eppler S;
Novotny W;
Lum B;
Gaudreault J

Publication type:

Journal Article

Obesity‐induced changes in gene expression in feline adipose and skeletal muscle tissue.

Published in:

Journal of Animal Physiology & Animal Nutrition, 2023, v. 107, n. 5, p. 1262, doi. 10.1111/jpn.13802

By:

Stenberg, Kathrine;
Novotny, Guy W.;
Lutz, Thomas A.;
Mandrup‐Poulsen, Thomas;
Bjørnvad, Charlotte Reinhard

Publication type:

Article

A population pharmacokinetic model for bevacizumab.

Published in:

Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 2, p. P91, doi. 10.1016/j.clpt.2003.11.347

By:

Lu, J.;
Gaudreault, J.;
Novotny, W.;
Lum, B.;
Bruno, R.

Publication type:

Article

Public policy and administration: A practitioner's reaction - A retrospective reconstruction.

Published in:

Public Administration Review, 1996, v. 56, n. 2, p. 158, doi. 10.2307/977202

By:

Novotny, Thomas W.

Publication type:

Article

Management's Hidden Enemy (Book).

Published in:

1988

By:

Novotny, Thomas W.

Publication type:

Book Review

MicroRNAs as regulators of beta-cell function and dysfunction.

Published in:

2016

By:

Osmai, Mirwais;
Osmai, Yama;
Bang‐Berthelsen, Claus H.;
Pallesen, Emil M. H.;
Vestergaard, Anna L.;
Novotny, Guy W.;
Pociot, Flemming;
Mandrup‐Poulsen, Thomas

Publication type:

journal article

Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster.

Published in:

2007

By:

Novotny, G. W.;
Sonne, S. B.;
Nielsen, J. E.;
Jonstrup, S. P.;
Hansen, M. A.;
Skakkebaek, N. E.;
Meyts, E. Rajpert-De;
Kjems, J.;
Leffers, H.

Publication type:

Letter

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.

Published in:

2009

By:

Buhl, A. M.;
Novotny, G. W.;
Josefsson, P.;
Nielsen, J. E.;
Pedersen, L. B.;
Geisler, C.;
Rassenti, L. Z.;
Kipps, T. J.;
Jurlander, J.;
Leffers, H.

Publication type:

Letter

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy.

Published in:

2019

By:

Holmström, Morten Orebo;
Novotny, Guy W.;
Petersen, Jesper;
Aaboe-Jørgensen, Mia;
Hasselbalch, Hans Carl;
Andersen, Mads H.;
Nielsen, Signe Ledou;
Fassi, Daniel El;
Schöllkopf, Claudia

Publication type:

Letter

Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours.

Published in:

2011

By:

Pan, Y;
Xu, R;
Peach, M;
Huang, C-P;
Branstetter, D;
Novotny, W;
Herbst, R S;
Eckhardt, S G;
Holland, P M

Publication type:

journal article